|
|
| | N-[(1S,2R)-1-[[[(1R)-1-[(3aS,4S,6S,7aR)-Hexahydro-3a,5,5-triMethyl-4,6-Methano-1,3,2-benzodioxaborol-2-yl]-3-Methylbutyl]aMino]carbonyl]-2-hydroxypropyl]-6-phenyl-2-pyridinecarboxaMide Basic information |
| Product Name: | N-[(1S,2R)-1-[[[(1R)-1-[(3aS,4S,6S,7aR)-Hexahydro-3a,5,5-triMethyl-4,6-Methano-1,3,2-benzodioxaborol-2-yl]-3-Methylbutyl]aMino]carbonyl]-2-hydroxypropyl]-6-phenyl-2-pyridinecarboxaMide | | Synonyms: | N-[(1S,2R)-1-[[[(1R)-1-[(3aS,4S,6S,7aR)-Hexahydro-3a,5,5-triMethyl-4,6-Methano-1,3,2-benzodioxaborol-2-yl]-3-Methylbutyl]aMino]carbonyl]-2-hydroxypropyl]-6-phenyl-2-pyridinecarboxaMide;MQRLCCDKPUEHCQ-ABRLXTPQSA-N;2-Pyridinecarboxamide, N-[(1S,2R)-1-[[[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]carbonyl]-2-hydroxypropyl]-6-phenyl- | | CAS: | 847494-64-8 | | MF: | C31H42BN3O5 | | MW: | 547.49 | | EINECS: | | | Product Categories: | Aromatics, Inhibitors, Pharmaceuticals, Intermediates & Fine Chemicals | | Mol File: | 847494-64-8.mol | ![N-[(1S,2R)-1-[[[(1R)-1-[(3aS,4S,6S,7aR)-Hexahydro-3a,5,5-triMethyl-4,6-Methano-1,3,2-benzodioxaborol-2-yl]-3-Methylbutyl]aMino]carbonyl]-2-hydroxypropyl]-6-phenyl-2-pyridinecarboxaMide Structure](CAS/20150408/GIF/847494-64-8.gif) |
| | N-[(1S,2R)-1-[[[(1R)-1-[(3aS,4S,6S,7aR)-Hexahydro-3a,5,5-triMethyl-4,6-Methano-1,3,2-benzodioxaborol-2-yl]-3-Methylbutyl]aMino]carbonyl]-2-hydroxypropyl]-6-phenyl-2-pyridinecarboxaMide Chemical Properties |
| Boiling point | 726.0±60.0 °C(Predicted) | | density | 1.20±0.1 g/cm3(Predicted) | | solubility | Chloroform, DCM, Methanol | | form | Solid | | pka | 11.93±0.46(Predicted) | | color | White |
| | N-[(1S,2R)-1-[[[(1R)-1-[(3aS,4S,6S,7aR)-Hexahydro-3a,5,5-triMethyl-4,6-Methano-1,3,2-benzodioxaborol-2-yl]-3-Methylbutyl]aMino]carbonyl]-2-hydroxypropyl]-6-phenyl-2-pyridinecarboxaMide Usage And Synthesis |
| Uses | N-[(1S,2R)-1-[[[(1R)-1-[(3aS,4S,6S,7aR)-Hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]carbonyl]-2-hydroxypropyl]-6-phenyl-2-pyridinecarboxamide is an intermediate in the synthesis of Delanzomib (D230710), an orally active proteasome inhibitor. |
| | N-[(1S,2R)-1-[[[(1R)-1-[(3aS,4S,6S,7aR)-Hexahydro-3a,5,5-triMethyl-4,6-Methano-1,3,2-benzodioxaborol-2-yl]-3-Methylbutyl]aMino]carbonyl]-2-hydroxypropyl]-6-phenyl-2-pyridinecarboxaMide Preparation Products And Raw materials |
|